Financial statements Solarpharma
Balance sheet of Solarpharma
Company age:
Age:
20 y. 3 m. 1 d.
Share capital:
Share capital:
51 000 PLN
Balance sheet data of SOLARPHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 49 976,14 | 31 548,97 | 119 649,86 | 99 036,55 | 137 458,69 | 115 276,38 |
| A. Fixed assets | 21 926,89 | 8 445,34 | 5 605,18 | 1 053,76 | 0,00 | 0,00 |
| B. Current assets | 28 049,25 | 23 103,63 | 114 044,68 | 97 982,79 | 137 458,69 | 115 276,38 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 49 976,14 | 31 548,97 | 119 649,86 | 99 036,55 | 137 458,69 | 115 276,38 |
| A. Equity | -51 577,56 | -93 285,32 | -97 985,16 | 58 410,83 | 46 601,26 | -96 793,16 |
| B. Liabilities and provisions for liabilities | 101 553,70 | 124 834,29 | 217 635,02 | 40 625,72 | 90 857,43 | 212 069,54 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.